Show simple item record

dc.contributor.authorCooke, GSen
dc.contributor.authorAndrieux-Meyer, Ien
dc.contributor.authorApplegate, TLen
dc.contributor.authorAtun, Ren
dc.contributor.authorBurry, JRen
dc.contributor.authorCheinquer, Hen
dc.contributor.authorDusheiko, Gen
dc.contributor.authorFeld, JJen
dc.contributor.authorGore, Cen
dc.contributor.authorGriswold, MGen
dc.contributor.authorHamid, Sen
dc.contributor.authorHellard, MEen
dc.contributor.authorHou, Jen
dc.contributor.authorHowell, Jen
dc.contributor.authorJia, Jen
dc.contributor.authorKravchenko, Nen
dc.contributor.authorLazarus, JVen
dc.contributor.authorLemoine, Men
dc.contributor.authorLesi, OAen
dc.contributor.authorMaistat, Len
dc.contributor.authorMcMahon, BJen
dc.contributor.authorRazavi, Hen
dc.contributor.authorRoberts, TRen
dc.contributor.authorSimmons, Ben
dc.contributor.authorSonderup, MWen
dc.contributor.authorSpearman, WCen
dc.contributor.authorTaylor, BEen
dc.contributor.authorThomas, DLen
dc.contributor.authorWaked, Ien
dc.contributor.authorWard, JWen
dc.contributor.authorWiktor, SZen
dc.date.accessioned2019-01-26T17:14:16Z
dc.date.available2019-01-26T17:14:16Z
dc.date.issued2019-02-01
dc.date.submitted2019-01-24
dc.identifier.citationAccelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. 2019, 4 (2):135-184 Lancet Gastroenterol Hepatolen
dc.identifier.issn2468-1253
dc.identifier.pmid30647010
dc.identifier.doi10.1016/S2468-1253(18)30270-X
dc.identifier.urihttp://hdl.handle.net/10144/619326
dc.description.abstractViral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV and tuberculosis. Highly effective prevention measures and treatments have made the global elimination of viral hepatitis a realistic goal, endorsed by all WHO member states. Ambitious targets call for a global reduction in hepatitis-related mortality of 65% and a 90% reduction in new infections by 2030. This Commission draws together a wide range of expertise to appraise the current global situation and to identify priorities globally, regionally, and nationally needed to accelerate progress. We identify 20 heavily burdened countries that account for over 75% of the global burden of viral hepatitis. Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020. In addition to further measures to improve access to vaccination and treatment, greater attention needs to be paid to access to affordable, high-quality diagnostics if testing is to reach the levels needed to achieve elimination goals. Simplified, decentralised models of care removing requirements for specialised prescribing will be required to reach those in need, together with sustained efforts to tackle stigma and discrimination. We identify key examples of the progress that has already been made in many countries throughout the world, demonstrating that sustained and coordinated efforts can be successful in achieving the WHO elimination goals.
dc.language.isoenen
dc.publisherElsevieren
dc.rightsArchived with thanks to The Lancet. Gastroenterology & Hepatologyen
dc.titleAccelerating the Elimination of Viral Hepatitis: a Lancet Gastroenterology & Hepatology Commission.en
dc.identifier.journalThe Lancet. Gastroenterology & Hepatologyen
refterms.dateFOA2019-03-04T14:17:39Z
html.description.abstractViral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV and tuberculosis. Highly effective prevention measures and treatments have made the global elimination of viral hepatitis a realistic goal, endorsed by all WHO member states. Ambitious targets call for a global reduction in hepatitis-related mortality of 65% and a 90% reduction in new infections by 2030. This Commission draws together a wide range of expertise to appraise the current global situation and to identify priorities globally, regionally, and nationally needed to accelerate progress. We identify 20 heavily burdened countries that account for over 75% of the global burden of viral hepatitis. Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020. In addition to further measures to improve access to vaccination and treatment, greater attention needs to be paid to access to affordable, high-quality diagnostics if testing is to reach the levels needed to achieve elimination goals. Simplified, decentralised models of care removing requirements for specialised prescribing will be required to reach those in need, together with sustained efforts to tackle stigma and discrimination. We identify key examples of the progress that has already been made in many countries throughout the world, demonstrating that sustained and coordinated efforts can be successful in achieving the WHO elimination goals.


Files in this item

Thumbnail
Name:
Cooke et al - 2019 - Accelerating ...
Size:
1.564Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record